BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Spruijt I, Tesfay Haile D, Suurmond J, van den Hof S, Koenders M, Kouw P, van Noort N, Toumanian S, Cobelens F, Goosen S, Erkens C. Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods study. Eur Respir J 2019;54:1900861. [DOI: 10.1183/13993003.00861-2019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Marx FM, Hauer B, Menzies NA, Haas W, Perumal N. Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis. BMC Public Health 2021;21:2172. [PMID: 34836526 DOI: 10.1186/s12889-021-12142-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Villa S, Ferrarese M, Sotgiu G, Castellotti PF, Saderi L, Grecchi C, Saporiti M, Raviglione M, Codecasa LR. Latent Tuberculosis Infection Treatment Completion while Shifting Prescription from Isoniazid-Only to Rifampicin-Containing Regimens: A Two-Decade Experience in Milan, Italy. J Clin Med 2019;9:E101. [PMID: 31906078 DOI: 10.3390/jcm9010101] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Nederby Öhd J, Hergens MP, Luksha Y, Buxbaum C, Shedrawy J, Jonsson J, Bruchfeld J, Lönnroth K. Evaluation of the latent tuberculosis screening and treatment strategy for asylum seekers in Stockholm, Sweden 2015-2018: a record linkage study of the care cascade. Eur Respir J 2021;57:2002255. [PMID: 32855227 DOI: 10.1183/13993003.02255-2020] [Reference Citation Analysis]
4 Spruijt I, Haile DT, Erkens C, van den Hof S, Goosen S, Ten Kate A, Teshome H, Karels M, Koenders M, Suurmond J. Strategies to reach and motivate migrant communities at high risk for TB to participate in a latent tuberculosis infection screening program: a community-engaged, mixed methods study among Eritreans. BMC Public Health 2020;20:315. [PMID: 32164637 DOI: 10.1186/s12889-020-8390-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
5 Rustage K, Lobe J, Hayward SE, Kristensen KL, Margineanu I, Stienstra Y, Goletti D, Zenner D, Noori T, Pareek M, Greenaway C, Friedland JS, Nellums LB, Hargreaves S; ESGITM and ESGMYC study groups. Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis. Lancet Infect Dis 2021:S1473-3099(21)00052-9. [PMID: 34363771 DOI: 10.1016/S1473-3099(21)00052-9] [Reference Citation Analysis]
6 Gafar F, Ochi T, Van't Boveneind-Vrubleuskaya N, Akkerman OW, Erkens C, van den Hof S, van der Werf TS, Alffenaar JC, Wilffert B. Towards elimination of childhood and adolescent tuberculosis in the Netherlands: an epidemiological time-series analysis of national surveillance data. Eur Respir J 2020;56:2001086. [PMID: 32471938 DOI: 10.1183/13993003.01086-2020] [Reference Citation Analysis]
7 Spruijt I, Haile DT, van den Hof S, Fiekert K, Jansen N, Jerene D, Klinkenberg E, Leimane I, Suurmond J. Knowledge, attitudes, beliefs, and stigma related to latent tuberculosis infection: a qualitative study among Eritreans in the Netherlands. BMC Public Health 2020;20:1602. [PMID: 33097021 DOI: 10.1186/s12889-020-09697-z] [Reference Citation Analysis]
8 Villa S, Codecasa LR, Faccini M, Pontello MM, Ferrarese M, Castellotti PF, Senatore S, Lamberti A, Mazzola E, Perno CF, Campisi D, Saporiti M, Raviglione MC. Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods study. Eur Respir J 2020;55:2000052. [DOI: 10.1183/13993003.00052-2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]